1-beta-d-arabinofuranosylcytosine 5'-monophosphate has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, CI; Nechaev, A; West, CR | 1 |
| Campbell, J; Mayhew, E; Rustum, YM; Szoka, F | 1 |
2 other study(ies) available for 1-beta-d-arabinofuranosylcytosine 5'-monophosphate and Leukemia L 1210
| Article | Year |
|---|---|
Nucleoside conjugates as potential antitumor agents. 2. Synthesis and biological activity of 1-(beta-D-arabinofuranosyl)cytosine conjugates of prednisolone and prednisone.
Topics: Animals; Antineoplastic Agents; Cell Division; Cytarabine; Female; Haplorhini; Hydrolysis; In Vitro Techniques; Leukemia L1210; Mice; Papio; Prednisolone; Prednisone | 1979 |
Inability of liposome encapsulated 1-beta-D-arabinofuranosylcytosine nucleotides to overcome drug resistance in L1210 cells.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cells, Cultured; Cytarabine; Cytidine Monophosphate; DNA, Neoplasm; Drug Resistance; Female; Leukemia L1210; Liposomes; Mice; Mice, Inbred DBA | 1981 |